Abbott Laboratories vs. CAMP4 Therapeutics Corporation Common Stock
ABT
Abbott Laboratories
$108.61 -0.17%
VS CAMPCAMP4 Therapeutics Corporation Common Stock
$4.48 -0.22%
Abbott Laboratories (ABT) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ABT | CAMP | |
|---|---|---|
| Market Cap | $188.25 billion | $281.76 million |
| Revenue (TTM) | $46.59 billion | $4.22 million |
| Net Income (TTM) | $5.42 billion | $-107,244,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | CAMP | |
|---|---|---|
| P/E Ratio | 35.15 | — |
| Price / Book | 3.64 | -406.58 |
| Price / Sales | 4.04 | 66.83 |
ABT and CAMP split the valuation factors evenly.
Profitability
| ABT | CAMP | |
|---|---|---|
| Net Margin | 11.65% | -2543.74% |
| Return on Equity | 10.48% | 15475.32% |
ABT and CAMP split the profitability factors evenly.
Dividend
| ABT | CAMP | |
|---|---|---|
| Dividend Yield | 2.32% | — |
| Payout Ratio | 81.55 | — |
ABT and CAMP split the dividend factors evenly.
Risk & Sentiment
| ABT | CAMP | |
|---|---|---|
| Short Interest | 0.57% | 2.82% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, CAMP overview, CAMP financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.